1.080DKK-2.26%Mkt Cap: 77.88M $P/E: —1d ago
BioPorto A/S, an in-vitro diagnostics company, focuses on developing biomarker tests to help clinicians detect the kidney injury in critically ill patients at earlier stage in Denmark, rest of Europe, North America, and …
Indicators:|
Key Statistics
Company
Market Cap77.88M $
Enterprise Value70.98M $
Revenue (TTM)5.87M $
Gross Profit4.43M $
Net Income (TTM)-11.96M $
Revenue/Share0.0109 USD
Last Price1.080 DKK
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees46
CountryDK
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-15.43
PEG—
EV/EBITDA-6.28
EV/Revenue12.10
P/S13.27
P/B8.50
EPS (TTM)-0.15
EPS (Forward)-0.07
52W Range
0.839035% of range1.526
52W High1.526 DKK
52W Low0.8390 DKK
Profitability
Gross Margin75.44%
Oper. Margin-107.49%
EBITDA Margin-192.72%
Profit Margin-203.83%
ROE-130.33%
ROA-88.13%
Growth
Revenue Growth47.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-11.22M $
CapEx (TTM)—
FCF Margin-114.23%
FCF Yield-8.61%
Net Debt-6.90M $
Net Debt/EBITDA0.61
Balance Sheet
Debt/Equity0.12
Current Ratio3.25
Quick Ratio2.81
Book Value/Sh0.1270 DKK
Cash/Share0.1110 DKK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 DKK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)1.750 DKK
Upside (mean)+62.0%
Target Range1.750 DKK – 1.750 DKK
# Analysts1
Ownership
Shares Out.495.10M
Float458.86M
Insiders29.80%
Institutions6.22%
Technical
SMA 501.163 (-7.1%)
SMA 2001.091 (-1.0%)
Beta1.38
S&P 52W Chg20.05%
Avg Vol (30d)393.28K
Avg Vol (10d)168.38K
Technical Indicators
RSI (14)37.6
MACD-0.0223
MACD Signal-0.0068
MACD Hist.-0.0155
BB Upper1.339 DKK
BB Middle1.183 DKK
BB Lower1.028 DKK
BB Width26.20%
ATR (14)0.0521 DKK
Vol Ratio (20d)0.49x